1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kuwait Pharmaceuticals and Healthcare Report Q1 2016

Kuwait Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 85 pages

BMI View

: Kuwait's pharmaceutical sector will remain insulated from the impact of lower oil prices giventhe country's strong fiscal buffers. Risks to our outlook include increasing generic penetration as healthinsurance coverage increases.

Headline Expenditure Projections

- Pharmaceuticals: From KWD287mn (USD1.01bn) in 2014 to KWD300mn (USD1.01bn) in 2015;+4.7% in local currency terms and +0.6% in US dollar terms. Forecast unchanged from Q415.

- Healthcare: From KWD1.53bn (USD5.38bn) in 2014 to KWD1.64bn (USD5.55bn) in 2015; +7.3% inlocal currency terms and +3.1% in US dollar terms. Forecast in line with Q415.

Table Of Contents

Kuwait Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kuwait 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2013-2019) 29
Industry Risk Reward Index 30
Middle East and Africa Risk/Reward Index - Q1 2016 30
Kuwait Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 43
Reimbursement Regime 45
Market Overview 50
Healthcare Sector 50
Epidemiology 57
Competitive Landscape 61
Domestic Pharmaceutical Sector 61
Table: Multinational Company Activity 63
Company Profile 65
Advanced Technology Company 65
Bader Sultan and Bros 67
Kuwait-Saudi Pharmaceutical Industries (KSP) 70
Safwan Trading And Contracting Company 72
Demographic Forecast 74
Table: Population Headline Indicators (Kuwait 1990-2025) 75
Table: Key Population Ratios (Kuwait 1990-2025) 75
Table: Urban/Rural Population and Life Expectancy (Kuwait 1990-2025) 76
Table: Population By Age Group (Kuwait 1990-2025) 76
Table: Population By Age Group % (Kuwait 1990-2025) 77
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Index Methodology 83
Index Overview 84
Table: Pharmaceutical Risk/Reward Index Indicators 84
Indicator Weightings 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.